Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 3 | 5 | -1,54 % | ||
| ARCELLX | 3 | 2 | 0,00 % | ||
| IDEAYA BIOSCIENCES | 2 | 3 | 0,00 % | ||
| ACADIA PHARMACEUTICALS | 2 | 1 | +2,36 % | ||
| MODERNA | 1 | 16 | -0,63 % | ||
| BIONTECH | 1 | 13 | +1,20 % | ||
| TANGO THERAPEUTICS | 1 | 3 | 0,00 % | ||
| AMICUS THERAPEUTICS | 1 | 1 | +0,82 % | ||
| SAVARA | 1 | - | +0,86 % | ||
| VANDA PHARMACEUTICALS | 1 | - | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12:46 | GILEAD SCIENCES, INC. - 8-K, Current Report | - | SEC Filings | ||
| 12:42 | Gilead Sciences To Acquire Arcellx | 105 | AFX News | FOSTER CITY (dpa-AFX) - Gilead Sciences (GILD) has entered into a definitive agreement to acquire Arcellx (ACLX) for $115 per share in cash at closing and one contingent value right of $5 per... ► Artikel lesen | |
| 12:36 | Gilead Sciences to buy Arcellx in deal worth up to $7.8B | 6 | Seeking Alpha | ||
| 12:36 | M&A Snapshot: Gilead acquires Arcellx for $7.8B | 5 | Seeking Alpha | ||
| 12:29 | Gilead Sciences To Acquire Arcellx | 6 | RTTNews | ||
| 12:22 | Gilead kündigt Übernahme von Arcellx für 7,8 Milliarden US-Dollar an | 7 | Investing.com Deutsch | ||
| 12:22 | IDEAYA Biosciences beruft Theodora Ross zur neuen Entwicklungschefin | 3 | Investing.com Deutsch | ||
| 12:18 | Gilead to acquire Arcellx for $7.8 billion in cash deal | 3 | Investing.com | ||
| 12:18 | IDEAYA Biosciences appoints Theodora Ross as development chief | 2 | Investing.com | ||
| 12:06 | Citizens reiterates Savara stock rating on likely FDA approval | 1 | Investing.com | ||
| 12:06 | MESOBLAST LTD - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 11:54 | Bicara Therapeutics stock rating reaffirmed by Citizens at Market Outperform | 2 | Investing.com | ||
| 11:46 | Citizens bestätigt Rating für Abivax nach neuen Studiendaten zu Colitis ulcerosa | 8 | Investing.com Deutsch | ||
| 11:42 | Mizuho upgrades Acadia Pharmaceuticals stock rating on remlifanserin potential | 1 | Investing.com | ||
| 11:42 | Citizens reiterates Abivax stock rating on ulcerative colitis data | 5 | Investing.com | ||
| 11:34 | Mizuho stuft Acadia Pharmaceuticals hoch: Potenzial von Remlifanserin im Fokus | 1 | Investing.com Deutsch | ||
| 11:18 | Biggest stock movers Monday: NVO, VNDA, and more | 12 | Seeking Alpha | ||
| 10:54 | Mizuho initiates Tango Therapeutics stock with outperform rating | 2 | Investing.com | ||
| 09:10 | J&J stoppt Rekrutierung in Alzheimer-Studie mit AC Immune | 23 | transkript.de | ||
| 09:02 | BIONTECH SE ADR zeigt strukturelle Stärke | 17 | Maximilian Berger |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.